Submission of Extract of Newspaper Publication of Unaudited (Standalone) Financials Results for the quarter ended on 31st December 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Johnson Pharmacare Limited has published its unaudited standalone financial results for the quarter ended 31st December 2025 in Republic India (English) and Samachar Today (Hindi) newspapers. The company reported zero total income from operations for the quarter. It posted a net loss of ₹6.40 lakhs for Q3 FY26, wider than the ₹2.99 lakh loss in the same quarter last year. For the nine months ended December 2025, the net loss stood at ₹7.06 lakhs, significantly smaller than the ₹58.38 lakh loss in the corresponding nine-month period of the previous year. Paid-up equity share capital remains at ₹5,500 lakhs, and basic/diluted EPS for the quarter was nearly zero. The results were approved by the Board on 14.02.2026.
The company continues to generate no revenue and is reporting losses, suggesting limited or dormant business operations. However, the year-to-date loss has narrowed sharply compared to the previous year, which is a modest positive signal for shareholders, though the overall financial health remains weak.